drugset / Trial / NCT01727024

Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients

NCT01727024

Phase 4 Completed 140 enrolled Novartis Pharmaceuticals
RandomizedCrossoverOpen-labelTreatment

Summary

This study compared the correct use of and patient preference for two drug delivery systems (inhalers) in patients with COPD

Timeline

Start
2013-04
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Indacaterol Other / unclassified 150 ug Inhaled
Comparator Tiotropium Other / unclassified 2.5 ug Inhaled